Acute Myelogenous Leukemia (AML)


Acute myeloid leukemia
AML vs. ALL
FAB system for defining AML
Pregnancy and AML
Secondary Leukemia after breast cancer treatment
Treatment for Acute Myeloid Leukemia

News
Addition of Gemtuzumab Ozogamicin Ups Survival in AML

Apr 9, 2012 - For patients with untreated de novo acute myeloid leukemia, the addition of gemtuzumab ozogamicin to standard frontline chemotherapy improves event-free, overall, and relapse-free survival, without causing excessive toxicity, according to a phase 3 study published online April 5 in The Lancet.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More